Activation of the muscarinic acetylcholine receptors requires agonist binding followed by a conformational change, but the ligand binding and conformationswitching residues have not been completely identified. Systematic alanine-scanning mutagenesis has been used to assess residues 142-164 in transmembrane helix 4 and 402-421 in transmembrane helix 7 of the M 1 muscarinic acetylcholine receptor. Several inward-facing amino acid side chains in the exofacial parts of transmembrane helices 4 and 7 contribute to acetylcholine binding. Alanine substitution of the aromatic residues in this group reduced signaling efficacy, suggesting that they may form part of a charge-stabilized aromatic cage, which triggers rotation and movement of the transmembrane helices. The mutation of adjacent residues modulated receptor activation, either reducing signaling or causing constitutive activation. In the buried endofacial section of transmembrane helix 7, alanine substitution mutants of the conserved NSXXNPXXY motif displayed strongly reduced signaling efficacy, despite having increased or unchanged acetylcholine affinity. These residues may have dual functions, forming intramolecular contacts that stabilize the receptor in the inactive ground state, but that are broken, allowing them to form new intramolecular bonds in the activated state. This conformational rearrangement is critical to produce a G protein binding site and may represent a key mechanism of receptor activation.
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Muscarinic acetylcholine receptors (mAChRs)
1 belong to the rhodopsin-like family of 7-transmembrane (7-TM) receptors. Agonists bind to these receptors at the extracellular end. This leads to the binding and activation of a G protein at the intracellular face. These receptors are characterized by the possession of a particular set of evolutionarily conserved amino acids, mostly located in the 7-TM helices, implying that they may share a common mechanism of activation. However, the topography of the binding pockets and the conformational changes related to agonist-induced receptor activation are incompletely understood. In recent studies on the M 1 mAChR, we have identified ligand contact residues in TM 3 (1), 5 (2), and 6 (3) and inferred a strip of residues in TM 3 contributing to the activated state of the M 1 mAChR by using alanine-scanning mutagenesis, or cysteine-scanning mutagenesis. The three-dimensional crystal structure of the ground state of rhodopsin at 2.8 Å (4) has provided a framework for modeling the mAChRs and allowed us to interpret most of the information obtained by mutagenesis studies on the M 1 mAChR.
In the initial projection map of rhodopsin (5), TM 4 appeared as an outlier of the helical bundle, with a large lipid-exposed surface and few polar residues. Consequently, its function has received little attention. However, a recent photo-activated chromophore cross-linking study of rhodopsin has shown a flip-over of the ionone ring from the neighborhood of TM 6 to TM 4 during receptor activation, implying that a substantial movement of TM 3 and/or 4 may accompany receptor activation (6). Site-directed mutagenesis studies have also indicated the potential importance of TM 4 in ligand binding and G protein recognition (7) (8) (9) .
As in other 7-TM receptors, particular residues in TM 7 of the mAChRs are known to contribute to ligand binding (10, 11) , but no comprehensive and systematic study of this domain of TM 7 has been performed. TM 7 also contains the very highly conserved NPXXY motif. Site-directed mutagenesis has been used to explore the functions of individual residues in this motif in several receptors (12) (13) (14) (15) (16) . This has led to two hypotheses. Reciprocal mutagenesis has suggested that the conserved Asn 7.50 (using the nomenclature of Ballesteros and Weinstein) may form part of a hydrogen bonding network involving the equally conserved Asp 2.50 and Asn 1.50 (12, 17) . In addition, a combinatorial histidine substitution study has provided evidence that Asn 7.50 may form part of a conserved set of Van der Waals contacts with TM 3 and 6, which stabilize the receptor in the ground state (13) .
The present alanine-scanning study was carried out in the context of a larger study of the TM domains of the M 1 mAChR (1-3), allowing the importance of individual residues to be compared, and evaluated in a receptor-wide context. Replacement of individual amino acids by alanine, which deletes the side-chain beyond the ␤-carbon with little perturbation of the overall structure of the receptor, allows primary categorization of the role of each amino acid. Important positions can be analyzed by the construction of further mutants. Taken with previous studies, the results now allow us to identify the majority of the residues in the acetylcholine binding site and to suggest how binding of the tetramethylammonium headgroup of ACh may trigger the receptor activation process.
EXPERIMENTAL PROCEDURES
The majority of experimental procedures were as described previously (1, 18). * This work was supported by the Medical Research Council, UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Tel.: 44-20-8959-3666; Fax: 44-20-8906-4477; E-mail: zlu@nimr.mrc.ac.uk. 1 The abbreviations used are: mAChR, muscarinic acetylcholine receptor; ACh, acetylcholine; TM, transmembrane domain; GPCRs, G protein-coupled receptors; NMS, (Ϫ)-N-methylscopolamine; QNB, (Ϫ)-3-quinuclidinyl benzilate; PhI, phosphoinositide.
Mutagenesis and Expression-Briefly, residues 142-164 and 402-421 of the rat M 1 mAChR were individually mutated to Ala (Ala itself was changed to Gly), using a polymerase chain reaction method. Mutant receptors, cloned into the pCD expression vector, and validated by di-deoxy sequencing, were transiently expressed in COS-7 cells by electroporation. Membrane preparations were made after 72 h as described previously (18) .
Binding (1, 18) .
Data Analysis-Ligand saturation binding curves were fitted to a one-site model to yield a total concentration of binding sites and an affinity constant, K NMS . Inhibition curves for ACh were fitted to the Hill equation, and the binding constants, K ACh , were corrected for the Cheng-Prusoff shift, as necessary (19) . PhI dose-response curves were fitted to a four-parameter logistic function, yielding an EC 50 value and a maximum response (E max ). Values of signaling efficacy, adjusted for variations in receptor expression, were calculated as described previously (1, 3, 18, 20) .
Molecular Modeling-A computer model of the M 1 mAChR, incorporating a 129-amino acid deletion from the third intracellular loop, was built on the solved structure of bovine rhodopsin (Protein Data Bank code 1F88 (4)). The construct that was modeled retains unchanged ligand binding properties and good signaling ability (18) . The model omits 20 amino acids at the N terminus. The crystal structure coordinates of rhodopsin were obtained from the Protein Data Bank (21) . The modeling software used was QUANTA (release 4.0, MSI) running on a Silicon Graphics INDIGO2 workstation under the UNIX operating system. The "Modeler" option (22) within QUANTA was used to build 20 models of the M 1 mAChR, including the conserved disulfide bridge. The different models were calculated by varying the initial model and optimizing the objective function using conjugate gradients and molecular dynamics with simulated annealing employing the CHARMM force field (23) . The model with the lowest objective function was used for manual docking of NMS and ACh. The phenyl ring of the tropic acid moiety of NMS was positioned to be equivalent to the ␤-ionone ring of retinal, causing the backbone of NMS to follow a path equivalent to that taken by the retinal chromophore in rhodopsin. TM helices 6 and 7 were moved as rigid bodies to relieve close contacts from residues in these helices.
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RESULTS
H-Labeled Antagonist Binding and Receptor
ExpressionSeveral Ala substitution mutations in the exofacial parts of TM 4 and 7 strongly reduced the affinity of the quaternary antagonist [ 3 H]NMS ( Fig. 1 ). W157A and P159A in TM 4 gave 123-and 63-fold reductions in NMS binding. A 13-fold reduction followed S153A. Three mutants in TM 7, Y404A, C407A, and Y408A, reduced NMS affinities by 25-, 19-and 48-fold, whereas, in contrast, N410A caused a 4-fold increase in affinity. However, only 6-to 9-fold reductions of NMS affinity were observed on the mutation of Tyr 404 and Tyr 408 to Phe. When examined with a second antagonist, [ 3 H]QNB, we unexpectedly found that mutations of Y404A, C407A, and Y408A had little effect on the binding of QNB (Fig. 1, legend) .
One mutation, Y408A, in the exofacial part of TM 7 and three mutations, W150A, N414A, and P415A, in the endofacial region of TM 4 and 7, decreased expression levels of [ 3 H]NMS binding sites to less than 6% of the wild-type level (Fig. 2) . Expression of these mutants was rescued to 46 -117% of wild-type level by 48-h preincubation of the transfected cells with 10 Ϫ6 M atropine as described previously (1). Mutation of Tyr 404 and Tyr 408 to Phe gave expression equivalent to 64 and 48% of the wild-type level, respectively. To examine the location of these receptors, we measured cell surface binding sites using the hydrophilic antagonist [ 3 H]NMS, on intact cells transfected with selected mutants. This gave results that were consistent with those obtained using membrane preparations (Fig. 2, legend) . Interestingly, the mutations T412A (TM 7) and M145A, L148A, L151A, A160G, and F163A (TM 4) showed slightly enhanced receptor expression.
Acetylcholine Binding-The binding of ACh to the wild-type M 1 mAChR, expressed in COS-7 cells, was characterized by a slightly flattened binding isotherm (n H ϭ 0.88) with an apparent affinity constant, K ACh of 1. onium headgroup of ACh, tetramethylammonium, giving a 3-fold lower affinity than the wild-type receptor. 2 As in the case of the His substitution mutations (13), Ala mutations of Asn 414 , Pro 415 , and Tyr 418 at the intracellular end of TM 7 strongly increased the affinity of ACh by between 15-to 22-fold (Fig. 3b) . The mutations A160G in TM4 and W405A, N410A, V413A, M416A, C417A, and C421A in TM 7 also caused 2-to 4-fold increases in the ACh affinity.
The Hill coefficients were unaltered for most mutations except for W157A, Y404A, and N410A, whose mutation led to a steep ACh binding curve (n H ϭ 1).
Effects on the PhI Response-ACh elicits a robust PhI response from COS-7 cells transfected with the wild-type M 1 mAChR, with an EC 50 value of 0.1 M, and an E max value equivalent to three times the basal activity. The effects of the Ala substitution mutations on the PhI response are summarized in Fig. 4 .
In TM 4, mutations that reduced ACh affinity also reduced ACh potency in eliciting the PhI response. The maximum responses given by W157A and P159A, which showed the largest reductions in potency, were also diminished. In TM 7, parallel effects on ACh binding and the functional response were seen in the exofacial region of the TM helix, although, interestingly, the maximum response given by the L402A mutation was reduced to 52% of wild-type without an effect on the ACh potency. The maximum PhI responses following Ala, but not the Phe substitutions of Tyr 404 and Tyr 408 were reduced. The mutations A160G and W405A caused constitutive activation, giving a basal activity equivalent to 12-20% of the E max of wild-type (Fig. 5) .
In contrast to the increases seen in ACh affinity, Ala substitutions of the highly conserved amino acids in the motif Asn 410 -Ser 411 -X-X-Tyr 414 -Pro 415 -X-X-Tyr 418 , located between the center and the C terminus of TM 7, generally reduced ACh potency. The maximum responses were also reduced to less than 75% of wild-type response. In particular, the N414A mutant completely failed to elicit a PhI response to ACh stimulation, even after atropine preincubation, which increased the 2 Z.-L. Lu, unpublished observations. Effects on Signaling Efficacy-Calculations of the ACh signaling efficacy were performed as described previously (1, 3, 18, 20) . These assessments distinguish the effects of mutations on the functional potency from the effects on the agonist affinity, taking into account changes in receptor expression levels. The results are summarized in Fig. 6 .
In the exofacial regions of TM 4 and 7, there was a 160-fold reduction for W157A, and 7-to 23-fold reductions for P159A, L402A, Y404A, and Y408A. The Y404F and Y408F mutations did not affect ACh signaling efficacy, whereas A160G and W405A caused 2-fold increases. In the endofacial region of TM 7, the mutation Y418A decreased ACh efficacy by 160-fold, whereas N414A gave essentially zero efficacy. Mutations of N410A, S411A, P415A, and A419G also gave a 4-to 12-fold reduction, whereas V413A and M416A caused 2-fold increases. With the exception of L402A, reductions in the E max values were seen when large reductions in the signaling efficacy of the mutants were calculated from the potency of ACh relative to its binding affinity.
DISCUSSION
Measurements of changes in binding and signaling, resulting from Ala substitution mutagenesis, help to elucidate the functions of the amino acid side chains studied, by distinguishing the null residues from those making contacts that contribute primarily to the ground state, the activated state(s), or both the ground and activated states of the receptor and its ligand complexes (24) .
Using this approach, we report all of the residues in TM 4 and 7 of the M 1 mAChR that have a role in ligand anchoring and signal transduction, as well as a set of residues that are critical for receptor stabilization and the on-off switch. Several of these residues have been targeted previously (8, 10, 11, 13, 25, 26) , but this is the first comprehensive study that allows their relative importance to be ranked and their role in receptor function to be analyzed.
The exofacial sequences of TM 4 and 7 are critical for binding both the agonist ACh, and the antagonist NMS. In TM 4 (2) . Analysis of signaling efficacy suggested that Trp 157 also has a very important role in transduction of ACh binding into receptor activation, whereas mutation of Pro 159 had a smaller effect. These were the only residues in TM 4 whose mutation strongly decreased signaling efficacy.
Trp 150 (4.50) probably makes important intramolecular contacts, because its mutation strongly reduced receptor expression, but these do not seem to be differentially involved in Ϫ1 , and the ratio of the maximum ACh-stimulated signal to the basal activity was 3.0 Ϯ 0.2. a, TM 4; b, TM 7. The N414A mutant was inactive in the PhI signaling. There were no significant changes in the basal activity for the mutant receptors in comparison with the parallel wild-type control, except for the A160G and W405A, which gave 161 Ϯ 16% and 140 Ϯ 4% of the wild-type basal. The E max values of the mutants were 100 Ϯ 6% the wild-type, except for W157A (31 Ϯ 7%), P159A (24 Ϯ 4%), L402A (52 Ϯ 3%), Y404A (70 Ϯ 4%), Y408A (48 Ϯ 3%), N410A (74 Ϯ 2%), S411A (73 Ϯ 5%), N414A (0%, when expressed at 5% or 117% of the wild-type level), P415A (66 Ϯ 12%, when expressed at 62% of the wild-type level), and Y418A (32 Ϯ 9%). formation of the activated state of the receptor, because signaling efficacy was unaffected. A precedent is set by Asp 122 and Tyr 124 in TM 3 (18) . In rhodopsin, the homologous tryptophan makes a hydrogen bond with TM 2 (4). Trp 4.50 is highly conserved, reflecting its structural importance in other members of the superfamily.
In TM 7, mutation of Tyr 404 (7.39) and Tyr 408 (7.43) to Phe reduced ACh affinity, but had smaller effects on NMS affinity, in agreement with studies on the M 3 mAChR (11). Removal of the aromatic ring, by mutation to Ala, gave a further reduction in NMS, but not ACh affinity. Interestingly, the affinity of the receptor for QNB was not affected by the mutation of Tyr 404 , Cys 407 and Tyr 408 , suggesting that QNB, unlike NMS, does not interact strongly with these residues. We have reported similar behavior for Tyr 381 (6.51) in TM 6 (3). These results clearly indicate that NMS and QNB have different binding modes, and contact different residues.
Ala, but not Phe mutations of Tyr 404 and Tyr 408 decreased ACh signaling efficacy. Again this behavior follows the model established by Tyr 381 . As we have proposed for the latter residue, the Tyr hydroxyl groups may participate in anchoring the agonist in the binding site, while the aromatic rings form part of an aromatic cage that closes around the tetramethylammonium headgroup of ACh to trigger receptor activation. It is likely that the two Tyr residues work in tandem, and it would be interesting to examine the properties of double mutant.
To aid interpretation of the mutagenesis results, a molecular model of the M 1 mAChR was built, based on the coordinates of the ground state structure of rhodopsin (4; see "Experimental Procedures"). A superposition of the results of the mutagenesis studies described in this and previous (1-3, 8, 11, 25, 26) studies is shown in Fig. 7 .
Residues whose Ala substitution reduced ACh affinity by at least 5- There is much overlap between NMS and ACh binding residues (Fig. 7, shown in yellow) . Several residues whose mutation reduced ACh but not NMS affinity (orange) occur near the top of TM (Fig. 8a) . This group includes seven of the nine residues whose Ala substitution mutation caused greater than 30- A recent transferred nuclear Overhauser effect NMR study of S-(ϩ)-acetyl-␤-methyl choline bound to the M 2 mAChR (27) has suggested that the conformer, which is bound in the ground state of the muscarinic binding site, is gauche, with an NCCO torsion angle of 60°. Assuming this to be true for the M 1 mAChR also, we have manually docked the gauche conformer of ACh into the model of the M 1 mAChR, placing the ester function of ACh in such a position that the carbonyl oxygen can hydrogen bond to the hydroxyl group of Tyr 381 , and the ester oxygen to the hydroxyl group of Tyr 106 , in agreement with a previous suggestion (3) .
Compared with the scopine headgroup of NMS, the tetramethylammonium headgroup of ACh occupies less volume within the binding cleft (Fig. 8b) . During activation, the charge-stabilized hydrophobic cage may close about the ACh headgroup, eliminating this cavity. This would explain why tetramethylammonium can activate mAChRs, whereas ethyl substitutions on the quaternary nitrogen of ACh strongly and progressively reduce efficacy, and, more generally, why muscarinic agonists of high efficacy have compact, positively charged headgroups (28) . Closure of the cage would necessitate movements of TM 6 and 7, relative to TM 3. In the ␤ 2 , NK1, and C5a receptors, and rhodopsin (30 -33) , a movement of the outer segment of TM 7 relative to TM 3 may also be important in activation.
Analysis of structure-activity data (29) shows the conformation of bound ACh to be trans (anticlinal) in the activated state of the receptor, with an NCCO angle of about 132°. This suggests that the transition of ACh from a gauche to an extended conformer may be part of the activation process. This could lead to a change in the hydrogen bonding pattern of the agonist. It has not proved possible to fit the trans conformer of ACh into the ground state model of the ACh binding site.
The pre-eminent role of Trp 157 in muscarinic ligand binding, and receptor activation, is harder to understand. In our model, the aromatic ring of Trp 157 is too far from the aromatic cage to act as a primary contact. There are several possibilities. One is that the effect of Trp 157 is indirect, stabilizing the primary aromatic cage by packing against it. The large effect of mutating Pro 159 is probably indirect, because its side chain faces the lipid bilayer (26) . A second is that a major conformational change occurs after ligand binding. In rhodopsin, a photoreactive retinal analogue, which labels TM 6 in the ground state, reacts with a position equivalent to Ala 158 (4.58) after activation (6) . A third possibility is that the position of TM 4 in the , located at the N terminus of TM 3. Asp 99 has been proposed to act as a primary contact residue before ligands enter the central binding site (34) . This cluster of amino acids may form a peripheral ligand contact site (Fig. 9) (13) . The finding that the corresponding Ala substitutions increase ACh affinity, or cause constitutive activation (1, 35) , suggests that such contacts may help to selectively stabilize the ground state of the receptor and may be disrupted during receptor activation.
In addition to these potential Van der Waals contacts, the rhodopsin structure and the model of the M 1 mAChR suggest that the highly conserved residues in the Asn -X-X-Tyr 418 motif are probably integrated into a network of hydrogen bonds connecting TM 7 to TM 1, TM 2, and TM 3 in the ground state of the receptor. The finding that mutations of these residues strongly reduced signaling efficacy, despite increased or unchanged (Ser 411 ) ACh affinity, implies that they have an additional role in stabilizing the active state of the agonist-receptor-G protein complex. It is likely that a new set of inter-helical hydrogen bonds forms in the activated state, possibly similar to that proposed by Weinstein and colleagues (36) . The conserved Asn-Pro motif is likely to mediate this conformational change through the kink and mobility which it introduces into this segment of TM 7. In rhodopsin (37) , this results in exposure of a buried epitope containing part of the highly conserved NPXXY motif, and a substantial increase in conformational mobility in the region of the H8 helix, as well as a rotation and outward movement of the cytoplasmic end of TM 6 (38) .
In summary, the inward-facing surfaces of the exofacial domains of TM 4 and 7 participate in ACh binding. Their aromatic residues may, together with those of TM 3 and 6, form a charge-stabilized aromatic cage that closes around the positively charged headgroup of ACh. In agreement with the hypothesis of Hibert et al. (39) , this would trigger relative rotations and translations of TM 3, 6, and 7, breaking the intramolecular constraints that stabilize the ground state and leading to receptor activation. The strongly conserved amino acids making up the NSXXNPXXY motif in the buried endofacial domain of TM 7 may have dual functions in the on-off interconversion. They may form intramolecular contacts that stabilize the receptor in the inactive ground state but are broken by agonist binding to the extracellular side, allowing them to build a new set of intramolecular contacts. The latter are crucial to maintain the receptor in the activated state and create an appropriate binding pocket for the G protein.
